BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Wednesday, May 6, 2026
Home » Authors » Amanda Pedersen

Articles by Amanda Pedersen

FDA clears OptiMedica's Catalys for corneal cuts

Sep. 5, 2012
By Amanda Pedersen
OptiMedica (Sunnyvale, California) has received FDA 510(k) clearance for its Catalys Precision laser system for creating single-plane and multi-plane arc cuts/incisions in the cornea during cataract surgery. The system, which was CE mark approved for these incisions earlier this year (Medical Device Daily, April 16, 2012), is now both CE mark approved and FDA cleared for this indication as well as capsulotomy and/or lens fragmentation.
Read More

Ability's RUSH foot promises 'radical simplicity' to amputees

Sep. 4, 2012
By Amanda Pedersen

Improvements seen in racial disparities for HF treatment

Aug. 31, 2012
By Amanda Pedersen

Aesthetics is going strong while orthopedics struggles

Aug. 29, 2012
By Amanda Pedersen

CMS 'Never Pay' rule is game changer for hospital CFOs

Aug. 28, 2012
By Amanda Pedersen

Deals roundup: Tornier to acquire OrthoHelix surgical designs for $135M

Aug. 27, 2012
By Amanda Pedersen
Tornier (Amsterdam, the Netherlands), a company that provides surgical solutions to orthopedic extremity specialists, has signed a definitive agreement to acquire OrthoHelix Surgical Designs (Medina, Ohio) for $135 million plus additional revenue-based milestone payments over two years. The transaction will consist of $100 million in cash and $35 million in Tornier stock.
Read More

Welcome to the future of healthcare

Aug. 24, 2012
By Amanda Pedersen
A few years ago Brad Paisley released “Welcome to the Future”, a song about all the changes he has seen in his lifetime and how some of the capabilities we have at our fingertips now, in terms of information technology, was merely a dream not that long ago. Paisley’s song has always struck a chord with me, pardon the pun, because our world is so fast-paced we don’t often pause long enough to think about the progress we have made. The same could be said for the medical device industry. A lot of devices that are in doctors’ hands today,...
Read More

Medical device recalls reach eight-quarter high

Aug. 24, 2012
By Amanda Pedersen

NewCo on the Go: Online medical device store to reduce costs to hospitals

Aug. 17, 2012
By Amanda Pedersen

Deals roundup: Teleflex to acquire LMA for about $276 million

Aug. 15, 2012
By Amanda Pedersen
Teleflex (Limerick, Pennsylvania), a provider of medical devices for critical care and surgery, said it signed a definitive agreement to acquire substantially all of the assets of LMA International (Singapore) for $343.5 million in Singapore dollars, which at current exchange rates translates into roughly U.S.$276 million.
Read More
Previous 1 2 … 95 96 97 98 99 100 101 102 103 … 222 223 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for May 5, 2026.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for May 5, 2026
  • Auvelity

    Axsome’s Auvelity cleared for large Alzheimer’s agitation market

    BioWorld
    Axsome Therapeutics Inc. won U.S. FDA approval for Auvelity (AXS-05) to treat Alzheimer’s disease agitation, a condition that affects up to three-quarters of...
  • The epidermal growth factor receptor in the inactive (left) and active (right) form.

    Cytospire raises £61M series A to target EGFR in solid tumors

    BioWorld
    Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
  • Strategy compass

    Bio Korea 2026: US policy risks shift to execution framework

    BioWorld
    Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing